Rankings
▼
Calendar
BMRN FY 2010 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$11B
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$376M
+15.9% YoY
Gross Profit
$306M
81.3% margin
Operating Income
$544,000
0.1% margin
Net Income
$206M
54.7% margin
EPS (Diluted)
$1.73
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
-$31M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$545M
Stockholders' Equity
$717M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$376M
$325M
+15.9%
Gross Profit
$306M
$259M
+18.3%
Operating Income
$544,000
$16M
-96.7%
Net Income
$206M
-$488,000
+42276.0%
← FY 2009
All Quarters
FY 2011 →